Small Business Research Programs: Better Data Could Improve Insight into Companies’ Success

Executive Summary

The GAO review of Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) awards shows a market-wide data gap that limits insight into commercialization outcomes. In FY 2024, 11 federal agencies issued $4.4 billion in SBIR/STTR awards, split almost equally between open and conventional topics. However, SBA’s statutorily required commercialization database is incomplete: for awards issued in FY 2019–FY 2024, small businesses submitted required commercialization data for less than half of their prior awards, and SBA officials say the data are not sufficiently reliable without validation or supplemental sources. The report also notes that Congress required DOD to release open topic solicitations beginning in FY 2023 and that statutory changes would be needed to change the commercialization data SBA collects.

Contractors across the tagged market segments should pay attention now because the incompleteness and limited reliability of commercialization reporting can affect program evaluation, congressional oversight, and future program design or resource allocation. Open-topic policies (including the DOD change noted in the report) create different proposal dynamics and potential opportunity structures versus conventional topics, but incomplete commercialization evidence makes it hard for decision makers to compare outcomes. Small businesses and their ecosystem partners should prioritize internal commercialization tracking and reporting readiness to both meet existing requirements and position themselves competitively as agencies and SBA consider validation or statutory changes.

Impact Matrix

Research and Development

• Risk Level: High
• Opportunity: Continued R&D funding via SBIR/STTR; open topics may create broader proposal space and novel problem-definition opportunities. Specific opportunities TBD pending solicitation language. Relevant NAICS codes: 541511, 541512, 541330, 541380, 541690, 541713, 541714, 541715, 541712 (from Tags).
• Timeline: FY 2019–FY 2024 (data window reviewed); FY 2024 awards; FY 2023 noted for DOD open-topic requirement.
• Action Required: Implement internal commercialization tracking for past and current awards; ensure required SBA reporting is completed; document commercialization metrics and evidence to survive prospective verification.
• Competitive Edge: Build validated, auditable commercialization records (revenues, contracts, licensing) and be prepared to share verifiable evidence to differentiate proposals and follow-on funding requests.

Technology Innovation

• Risk Level: High
• Opportunity: Open topics enable proposing novel technology solutions aligned to broad agency interests; conventional topics target agency-defined problems. Specific opportunities TBD pending solicitation language.
• Timeline: FY 2024 (current awards) and FY 2019–FY 2024 reporting period.
• Action Required: Prioritize capturing commercialization indicators (customers, revenue, follow-on funding) for SBIR/STTR awards and confirm applicants submit SBA-required reports.
• Competitive Edge: Present commercialization-ready plans and early customer traction in proposals; create standard evidence packages to accelerate verification.

Small Business Programs

• Risk Level: Critical
• Opportunity: Programs remain a primary route to R&D funding for small firms; SBIR/STTR remain key vehicles. Vehicles: SBIR, STTR (from Tags). Specific solicitation details TBD.
• Timeline: FY 2019–FY 2024 data reviewed; FY 2024 awards noted.
• Action Required: Ensure understanding of SBA reporting obligations and integrate reporting timelines into post-award workflows; monitor SBA outreach and any statutory or data-collection changes.
• Competitive Edge: Implement compliance-first post-award processes that ensure higher reporting completion and produce verifiable commercialization outcomes.

Defense Technology

• Risk Level: High
• Opportunity: DOD’s move to require open-topic solicitations beginning FY 2023 expands avenues for proposer-defined solutions. Specific program solicitations TBD pending agency releases. Agencies listed include DOD (from Tags).
• Timeline: DOD open-topic requirement began in FY 2023; FY 2024 awards are included in the GAO review.
• Action Required: For defense-focused small businesses, adapt to open-topic proposal formats; document downstream commercialization to federal and commercial customers.
• Competitive Edge: Demonstrate dual-use/commercialization plans and compiled evidence showing transition potential to defense and commercial markets.

Biotechnology

• Risk Level: Medium-High
• Opportunity: SBIR/STTR funding supports biotech R&D and potential commercialization into private industry or federal procurement. Specific opportunities TBD pending solicitation language. NAICS codes from Tags may be relevant.
• Timeline: FY 2019–FY 2024 data window; FY 2024 awards.
• Action Required: Track clinical/market milestones and revenue/license outcomes required by SBA reporting; prepare verifiable documentation.
• Competitive Edge: Aggregate clinical, licensing, and revenue evidence into standardized commercialization dossiers for verification.

Advanced Manufacturing

• Risk Level: Medium-High
• Opportunity: Awarded projects across manufacturing-relevant NAICS may leverage SBIR/STTR to mature processes/products. Specific opportunities TBD pending solicitation language. NAICS codes from Tags apply.
• Timeline: FY 2019–FY 2024; FY 2024 awards.
• Action Required: Capture manufacturing adoption, supplier contracts, or sales as commercialization metrics; ensure SBA reports reflect these outcomes.
• Competitive Edge: Develop supply-chain and customer adoption evidence to establish commercialization claims.

Information Technology

• Risk Level: High
• Opportunity: IT firms can pursue both open and conventional topics; SBIR/STTR remain primary vehicles. Specific opportunities TBD pending solicitation language. Relevant NAICS codes are in Tags.
• Timeline: FY 2024 awards and FY 2019–FY 2024 data window.
• Action Required: Track customer deployments, recurring revenue, and licensing; ensure timely SBA reporting and prepare for possible validation steps.
• Competitive Edge: Offer live customer references, revenue records, and third-party usage metrics to substantiate commercialization claims.

Energy Technology

• Risk Level: Medium
• Opportunity: Agencies participating include DOE (from Tags) and others; energy tech teams can pursue SBIR/STTR funding to advance commercialization. Specific opportunities TBD pending solicitation language.
• Timeline: FY 2019–FY 2024; FY 2024 awards.
• Action Required: Document pilot deployments, sales, and licensing; align internal reporting with SBA requirements.
• Competitive Edge: Compile measurable energy performance and commercial contract evidence to support commercialization reporting.

Medical Devices

• Risk Level: Medium-High
• Opportunity: Medical device firms can leverage SBIR/STTR for early-stage development and commercialization. Specific opportunities TBD pending solicitation language. Agencies in Tags include HHS, NIH components implied by HHS but detailed programs are TBD pending source review.
• Timeline: FY 2019–FY 2024; FY 2024 awards.
• Action Required: Maintain records of regulatory milestones, sales, and licensing for SBA reporting and possible verification.
• Competitive Edge: Present validated clinical/commercial outcomes and payer/reimbursement evidence to strengthen commercialization claims.

Aerospace

• Risk Level: Medium-High
• Opportunity: Aerospace firms can pursue SBIR/STTR through participating agencies such as NASA (from Tags) and DOD. Specific solicitations TBD.
• Timeline: FY 2019–FY 2024; FY 2024 awards.
• Action Required: Capture transition agreements, subcontracting to prime integrators, and sales as commercialization evidence for SBA reports.
• Competitive Edge: Document transition paths to prime contractors and government customers with verifiable agreements.

Cybersecurity

• Risk Level: High
• Opportunity: Cybersecurity solutions are viable in both open and conventional topics across multiple agencies. Specific opportunities TBD pending solicitation language. Agencies in Tags include DHS (Department of Homeland Security), DOD, DOC, etc.
• Timeline: FY 2019–FY 2024; FY 2024 awards.
• Action Required: Record deployments, subscriptions, and customer contracts to satisfy SBA commercialization reporting and potential validation.
• Competitive Edge: Provide audit-ready deployment metrics, contracts, and third-party validation to substantiate commercialization.

Artificial Intelligence

• Risk Level: High
• Opportunity: AI firms can target broad open topics and problem-specific conventional topics across agencies. Specific opportunities TBD pending solicitation language.
• Timeline: FY 2019–FY 2024; FY 2024 awards.
• Action Required: Track production deployments, revenue, and follow-on contracts; prepare data that can be validated.
• Competitive Edge: Offer measurable performance and customer adoption metrics with traceable commercial receipts.

Materials Science

• Risk Level: Medium
• Opportunity: Materials science projects funded via SBIR/STTR can translate to advanced manufacturing, aerospace, or energy uses. Specific opportunities TBD pending solicitation language.
• Timeline: FY 2019–FY 2024; FY 2024 awards.
• Action Required: Capture licensing, sales to industry, and demonstration contracts; ensure SBA-reporting compliance.
• Competitive Edge: Consolidate material test-article sales, licensing agreements, and industry adoption evidence for rapid verification.

Cross-Segment Implications

• Incomplete and unreliable commercialization data impedes cross-segment comparisons and limits decision makers’ ability to assess economic return across R&D, defense, biotech, IT, and other sectors. This affects portfolio prioritization and could slow policy or programmatic changes that rely on robust outcome metrics.
• The DOD open-topic requirement beginning FY 2023 increases the importance of being able to show commercialization potential for defense and dual-use technologies (affecting Defense Technology, Aerospace, Cybersecurity, AI, Materials Science). If SBA or agencies move to validate commercialization data (per SBA officials’ stated options), firms that already maintain auditable commercialization records will gain a competitive advantage across multiple segments.
• Any future statutory or data-collection changes (statutory changes are noted as required in the GAO summary) would likely have system-wide effects on reporting burden and on what evidence agencies and SBA can rely on; firms that streamline data capture now will be better positioned for both compliance and competitiveness.